BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in BioCardia, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +1 vs. Q4 2021
- Shares held
- 2.65M
- −329.1K (−11.0%) vs. Q4 2021
- Total value
- $5.49M
- −$293.0K (−5.1%) vs. Q4 2021
- New holders
- 5
- 5 more added
- Sold out
- 4
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 70 | $0 | 0.00% | +1+1.4% | Added |
| Morgan Stanley | 983 | $2.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,000 | $2.00K | 0.00% | +1,000 | New |
| UBS Group AG | 1,694 | $4.00K | 0.00% | −4,119−70.9% | Reduced |
| Simplex Trading, LLC | 2,855 | $5.00K | 0.00% | −7,894−73.4% | Reduced |
| Bank of America Corp | 6,528 | $14.0K | 0.00% | −14−0.2% | Reduced |
| LPL Financial LLC | 11,050 | $23.0K | 0.00% | +11,050 | New |
| Bank of New York Mellon Corp | 12,854 | $27.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 13,700 | $28.0K | 0.00% | +13,700 | New |
| Northern Trust Corp | 19,226 | $40.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,000 | $43.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 27,407 | $57.0K | 0.00% | +27,407 | New |
| Brown Advisory Inc | 33,085 | $68.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 34,488 | $71.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 34,431 | $72.0K | 0.00% | −1,683−4.7% | Reduced |
| Citadel Advisors LLC | 43,695 | $90.0K | 0.00% | −8,281−15.9% | Reduced |
| Commonwealth Equity Services, LLC | 49,978 | $103.0K | 0.00% | +7,671+18.1% | Added |
| Susquehanna International Group, LLP | 72,328 | $150.0K | 0.00% | +6,537+9.9% | Added |
| Geode Capital Management, LLC | 87,555 | $181.0K | 0.00% | +10,730+14.0% | Added |
| CM Management, LLC | 329,000 | $681.0K | 0.57% | 00.0% | Unchanged |
| Roumell Asset Management, LLC | 536,497 | $1.11M | 1.80% | −401,883−42.8% | Reduced |
| Vanguard Group Inc | 650,523 | $1.35M | 0.00% | +238,554+57.9% | Added |
| Captrust Financial Advisors | 660,637 | $1.37M | 0.01% | 00.0% | Unchanged |
| IFP Advisors, Inc | 100 | – | – | +100 | New |
| Family Management Corp | 0 | $0 | 0.00% | −142,186−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −56,419−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −21,196−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,200−100.0% | Sold out |